# Anheuser-Busch InBev SA: financial statements, quarterly

BUD · NYSE · CIK 1668717 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bud.md) · [Financials](/companies/bud/financials.md) · [Filings](/companies/bud/filings.md) · [Insiders](/companies/bud/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bud/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | [8.6](/filings/0001193125-18-107544.md) | [10.5](/filings/0001193125-20-082866.md) | [7.1](/filings/0001193125-20-082866.md) | [7.2](/filings/0001193125-21-087552.md) | [15.3](/filings/0001193125-22-079594.md) | [12.1](/filings/0001193125-23-073993.md) | [10.0](/filings/0001193125-24-064823.md) | [10.3](/filings/0001193125-25-052976.md) | [11.2](/filings/0001193125-26-088105.md) | [11.6](/filings/0001193125-26-088105.md) |
| Current assets | $bn | not reported | not reported | [43.0](/filings/0001193125-18-107544.md) | [24.0](/filings/0001193125-20-082866.md) | [18.3](/filings/0001193125-20-082866.md) | [28.8](/filings/0001193125-21-087552.md) | [26.5](/filings/0001193125-22-079594.md) | [23.9](/filings/0001193125-23-073993.md) | [23.2](/filings/0001193125-24-064823.md) | [23.4](/filings/0001193125-25-052976.md) | [23.0](/filings/0001193125-26-088105.md) | [24.8](/filings/0001193125-26-088105.md) |
| Total assets | $bn | not reported | not reported | [257](/filings/0001193125-18-107544.md) | [248](/filings/0001193125-20-082866.md) | [234](/filings/0001193125-20-082866.md) | [237](/filings/0001193125-21-087552.md) | [226](/filings/0001193125-22-079594.md) | [218](/filings/0001193125-23-073993.md) | [213](/filings/0001193125-24-064823.md) | [219](/filings/0001193125-25-052976.md) | [207](/filings/0001193125-26-088105.md) | [219](/filings/0001193125-26-088105.md) |
| Current liabilities | $bn | not reported | not reported | [40.4](/filings/0001193125-18-107544.md) | [36.6](/filings/0001193125-20-082866.md) | [34.8](/filings/0001193125-20-082866.md) | [34.8](/filings/0001193125-21-087552.md) | [32.4](/filings/0001193125-22-079594.md) | [34.2](/filings/0001193125-23-073993.md) | [34.4](/filings/0001193125-24-064823.md) | [37.2](/filings/0001193125-25-052976.md) | [33.1](/filings/0001193125-26-088105.md) | [34.5](/filings/0001193125-26-088105.md) |
| Shareholders' equity | $bn | [54.3](/filings/0001193125-18-107544.md) | [45.7](/filings/0001193125-19-083684.md) | [71.3](/filings/0001193125-18-107544.md) | [72.6](/filings/0001193125-20-082866.md) | [64.5](/filings/0001193125-20-082866.md) | [75.7](/filings/0001193125-21-087552.md) | [68.0](/filings/0001193125-22-079594.md) | [68.7](/filings/0001193125-23-073993.md) | [73.4](/filings/0001193125-24-064823.md) | [81.8](/filings/0001193125-25-052976.md) | [78.2](/filings/0001193125-26-088105.md) | [87.3](/filings/0001193125-26-088105.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,797,199,994 at 2025-12-31, from the cover of the [20-F filed 2026-03-03](/filings/0001193125-26-088105.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. No prices; not investment advice.